Draft v3 · · What changed
Dario Amodei
Amodei is the most articulate scaling-pilled safety advocate in frontier AI; the gap between his measured public register and the leaked-memo register has, by 2026, become the structural fact about him, and the four arguments he is best known for each carry the same internal tension between the public and private versions of the same case.
Positions
The bet at the end of the curve
Amodei has held one scaling hypothesis since 2017: more compute buys smooth, predictable gains, and "powerful AI" may arrive as early as 2026. He named the result that would change his mind; no one has reported it.
The prototype that nobody codified
Amodei pitched Anthropic's Responsible Scaling Policy as a prototype for regulation. No US federal rule has followed, rival frameworks have loosened, and the voluntary version is starting to look permanent.
Machines of Loving Grace, and the question biology isn't quite built to answer
Amodei's compressed-century forecast treats intelligence as what limits biomedical progress. His sharpest critics say the limits are physical: experiments, cell growth and measurement tools that keep their own pace…
The chip-controls bet, two years on
Amodei's export-control case rests on a mechanism, reinvested efficiency gains, and a wager that a US lead of up to two years holds through 2027, or 2030 at the latest. The compute curve decides whether that lead…
The Altman divergence
Amodei and Altman both bet on scaling and differ on what it is for: biology and risk for one, economic abundance for the other. Each built a voluntary safeguard; both have since given ground.
·Issue 1 · The Scaling Bet
deslop.media editorial. Issue 1, Draft v3, first published October 10, 2026. Reporting current through October 2026. Use the flags on this page to report an error or a disagreement. Changes to the issue are listed on the changes page.
Part of Issue 1 · The Scaling Bet